• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

足细胞损伤的机制及其在糖尿病肾病中的意义。

Mechanisms of podocyte injury and implications for diabetic nephropathy.

机构信息

Department of Medical Sciences, University of Turin, Turin, Italy.

出版信息

Clin Sci (Lond). 2022 Apr 14;136(7):493-520. doi: 10.1042/CS20210625.

DOI:10.1042/CS20210625
PMID:35415751
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9008595/
Abstract

Albuminuria is the hallmark of both primary and secondary proteinuric glomerulopathies, including focal segmental glomerulosclerosis (FSGS), obesity-related nephropathy, and diabetic nephropathy (DN). Moreover, albuminuria is an important feature of all chronic kidney diseases (CKDs). Podocytes play a key role in maintaining the permselectivity of the glomerular filtration barrier (GFB) and injury of the podocyte, leading to foot process (FP) effacement and podocyte loss, the unifying underlying mechanism of proteinuric glomerulopathies. The metabolic insult of hyperglycemia is of paramount importance in the pathogenesis of DN, while insults leading to podocyte damage are poorly defined in other proteinuric glomerulopathies. However, shared mechanisms of podocyte damage have been identified. Herein, we will review the role of haemodynamic and oxidative stress, inflammation, lipotoxicity, endocannabinoid (EC) hypertone, and both mitochondrial and autophagic dysfunction in the pathogenesis of the podocyte damage, focussing particularly on their role in the pathogenesis of DN. Gaining a better insight into the mechanisms of podocyte injury may provide novel targets for treatment. Moreover, novel strategies for boosting podocyte repair may open the way to podocyte regenerative medicine.

摘要

蛋白尿是原发性和继发性蛋白尿性肾小球疾病的标志,包括局灶节段性肾小球硬化症(FSGS)、肥胖相关性肾病和糖尿病肾病(DN)。此外,蛋白尿是所有慢性肾脏病(CKD)的一个重要特征。足细胞在维持肾小球滤过屏障(GFB)的选择性方面起着关键作用,足细胞损伤导致足突融合和足细胞丢失,这是蛋白尿性肾小球疾病的统一潜在机制。高血糖引起的代谢损伤在 DN 的发病机制中至关重要,而导致足细胞损伤的损伤因素在其他蛋白尿性肾小球疾病中尚未明确。然而,已经确定了足细胞损伤的共同机制。在此,我们将综述血流动力学和氧化应激、炎症、脂毒性、内源性大麻素(EC)高张力以及线粒体和自噬功能障碍在足细胞损伤发病机制中的作用,特别关注它们在 DN 发病机制中的作用。深入了解足细胞损伤的机制可能为治疗提供新的靶点。此外,促进足细胞修复的新策略可能为足细胞再生医学开辟道路。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5f4/9008595/c42418a56550/cs-136-cs20210625-g3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5f4/9008595/2a082fe209b6/cs-136-cs20210625-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5f4/9008595/a785209322da/cs-136-cs20210625-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5f4/9008595/c42418a56550/cs-136-cs20210625-g3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5f4/9008595/2a082fe209b6/cs-136-cs20210625-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5f4/9008595/a785209322da/cs-136-cs20210625-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5f4/9008595/c42418a56550/cs-136-cs20210625-g3.jpg

相似文献

1
Mechanisms of podocyte injury and implications for diabetic nephropathy.足细胞损伤的机制及其在糖尿病肾病中的意义。
Clin Sci (Lond). 2022 Apr 14;136(7):493-520. doi: 10.1042/CS20210625.
2
Protective effect of the tunneling nanotube-TNFAIP2/M-sec system on podocyte autophagy in diabetic nephropathy.隧道纳米管-TNFAIP2/M-sec 系统对糖尿病肾病足细胞自噬的保护作用。
Autophagy. 2023 Feb;19(2):505-524. doi: 10.1080/15548627.2022.2080382. Epub 2022 Jun 6.
3
Enhanced Levels of Glycosphingolipid GM3 Delay the Progression of Diabetic Nephropathy.糖脂神经酰胺 GM3 水平升高可延缓糖尿病肾病的进展。
Int J Mol Sci. 2023 Jul 12;24(14):11355. doi: 10.3390/ijms241411355.
4
Wnt/beta-catenin signaling promotes podocyte dysfunction and albuminuria.Wnt/β-连环蛋白信号通路促进足细胞功能障碍和蛋白尿。
J Am Soc Nephrol. 2009 Sep;20(9):1997-2008. doi: 10.1681/ASN.2009010019. Epub 2009 Jul 23.
5
Emerging role of podocyte autophagy in the progression of diabetic nephropathy.足细胞自噬在糖尿病肾病进展中的新作用。
Autophagy. 2015;11(12):2385-6. doi: 10.1080/15548627.2015.1115173.
6
Regulation of TRPC6 ion channels in podocytes - Implications for focal segmental glomerulosclerosis and acquired forms of proteinuric diseases.足细胞中TRPC6离子通道的调节——对局灶节段性肾小球硬化和获得性蛋白尿疾病的影响
Acta Physiol Hung. 2015 Sep;102(3):241-51. doi: 10.1556/036.102.2015.3.2.
7
Podocyte injury of diabetic nephropathy: Novel mechanism discovery and therapeutic prospects.糖尿病肾病足细胞损伤:新机制发现与治疗前景。
Biomed Pharmacother. 2023 Dec;168:115670. doi: 10.1016/j.biopha.2023.115670. Epub 2023 Oct 13.
8
Tangshen formula protects against podocyte apoptosis via enhancing the TFEB-mediated autophagy-lysosome pathway in diabetic nephropathy.糖肾方通过增强TFEB介导的自噬-溶酶体途径保护糖尿病肾病中的足细胞凋亡。
J Ethnopharmacol. 2024 Apr 24;324:117721. doi: 10.1016/j.jep.2024.117721. Epub 2024 Jan 8.
9
Mangiferin prevents diabetic nephropathy progression and protects podocyte function via autophagy in diabetic rat glomeruli.芒果苷通过自噬防止糖尿病大鼠肾小球中糖尿病肾病的进展并保护足细胞功能。
Eur J Pharmacol. 2018 Apr 5;824:170-178. doi: 10.1016/j.ejphar.2018.02.009. Epub 2018 Feb 11.
10
Podocyte injury: the role of proteinuria, urinary plasminogen, and oxidative stress.足细胞损伤:蛋白尿、尿纤溶酶原及氧化应激的作用
Am J Physiol Renal Physiol. 2016 Dec 1;311(6):F1308-F1317. doi: 10.1152/ajprenal.00162.2016. Epub 2016 Jun 22.

引用本文的文献

1
Exploring the protective role of DDIT4/mTOR in podocyte integrity through macrophage polarization in diabetic kidney disease.通过巨噬细胞极化探讨DDIT4/mTOR在糖尿病肾病足细胞完整性中的保护作用。
Ren Fail. 2025 Dec;47(1):2546623. doi: 10.1080/0886022X.2025.2546623. Epub 2025 Sep 7.
2
Research on podocyte injury mechanisms in diabetic nephropathy: a bibliometric and knowledge-map analysis from 2000 to 2024.糖尿病肾病中足细胞损伤机制的研究:2000年至2024年的文献计量学与知识图谱分析
Front Endocrinol (Lausanne). 2025 Aug 11;16:1578045. doi: 10.3389/fendo.2025.1578045. eCollection 2025.
3
Diabetic kidney disease: from pathogenesis to multimodal therapy-current evidence and future directions.

本文引用的文献

1
A glomerular transcriptomic landscape of apolipoprotein L1 in Black patients with focal segmental glomerulosclerosis.载脂蛋白 L1 在黑人局灶节段性肾小球硬化症患者肾小球转录组中的特征。
Kidney Int. 2022 Jul;102(1):136-148. doi: 10.1016/j.kint.2021.10.041. Epub 2021 Dec 18.
2
Quantification of Glomerular Structural Lesions: Associations With Clinical Outcomes and Transcriptomic Profiles in Nephrotic Syndrome.肾小球结构损伤的量化:与肾病综合征临床结局和转录组图谱的关联
Am J Kidney Dis. 2022 Jun;79(6):807-819.e1. doi: 10.1053/j.ajkd.2021.10.004. Epub 2021 Dec 3.
3
Kidney disease in diabetes: From mechanisms to clinical presentation and treatment strategies.
糖尿病肾病:从发病机制到多模式治疗——当前证据与未来方向
Front Med (Lausanne). 2025 Aug 8;12:1631053. doi: 10.3389/fmed.2025.1631053. eCollection 2025.
4
Research progress in the treatment of lipid metabolism disorder in patients with diabetic kidney disease by the integrated traditional Chinese and Western medicine.中西医结合治疗糖尿病肾病患者脂质代谢紊乱的研究进展
Front Endocrinol (Lausanne). 2025 Jul 30;16:1631312. doi: 10.3389/fendo.2025.1631312. eCollection 2025.
5
Research progress on non-coding RNA regulatory networks and targeted therapy in diabetic nephropathy.糖尿病肾病中非编码RNA调控网络与靶向治疗的研究进展
Front Endocrinol (Lausanne). 2025 Jul 29;16:1625307. doi: 10.3389/fendo.2025.1625307. eCollection 2025.
6
The role of macrophages in renal fibrosis and therapeutic prospects.巨噬细胞在肾纤维化中的作用及治疗前景。
PeerJ. 2025 Jul 23;13:e19769. doi: 10.7717/peerj.19769. eCollection 2025.
7
LCZ696 improves oxidative stress injury in human podocytes induced by increased glucose levels via Nrf2/HO-1 signaling pathway.LCZ696通过Nrf2/HO-1信号通路改善高糖诱导的人足细胞氧化应激损伤。
Eur J Med Res. 2025 Jul 9;30(1):598. doi: 10.1186/s40001-025-02883-y.
8
Modulation of podocyte extracellular matrix remodeling in membranous nephropathy by the NFATc3/LRRC55/BK channel pathway.NFATc3/LRRC55/BK通道通路对膜性肾病中足细胞细胞外基质重塑的调节作用
J Cell Commun Signal. 2025 Jun 13;19(2):e70022. doi: 10.1002/ccs3.70022. eCollection 2025 Jun.
9
Reduced nephrin tyrosine phosphorylation impairs podocyte force transmission and accelerates detachment in disease.肾足蛋白酪氨酸磷酸化减少会损害足细胞的力传递,并加速疾病中的脱离。
iScience. 2025 May 14;28(6):112673. doi: 10.1016/j.isci.2025.112673. eCollection 2025 Jun 20.
10
Pericytes and Diabetic Microangiopathies: Tissue Resident Mesenchymal Stem Cells with High Plasticity and Regenerative Capacity.周细胞与糖尿病微血管病变:具有高可塑性和再生能力的组织驻留间充质干细胞
Int J Mol Sci. 2025 Jun 1;26(11):5333. doi: 10.3390/ijms26115333.
糖尿病肾病:从发病机制到临床特征及治疗策略。
Metabolism. 2021 Nov;124:154890. doi: 10.1016/j.metabol.2021.154890. Epub 2021 Sep 22.
4
Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes.在肾脏病和 2 型糖尿病患者中用非奈利酮发生的心血管事件。
N Engl J Med. 2021 Dec 9;385(24):2252-2263. doi: 10.1056/NEJMoa2110956. Epub 2021 Aug 28.
5
Hyperglycemia alters mitochondrial respiration efficiency and mitophagy in human podocytes.高血糖改变人足细胞中线粒体呼吸效率和线粒体自噬。
Exp Cell Res. 2021 Oct 1;407(1):112758. doi: 10.1016/j.yexcr.2021.112758. Epub 2021 Aug 23.
6
Twist1 in podocytes ameliorates podocyte injury and proteinuria by limiting CCL2-dependent macrophage infiltration.足细胞中的Twist1通过限制CCL2依赖性巨噬细胞浸润来减轻足细胞损伤和蛋白尿。
JCI Insight. 2021 Aug 9;6(15):e148109. doi: 10.1172/jci.insight.148109.
7
Compounds targeting OSBPL7 increase ABCA1-dependent cholesterol efflux preserving kidney function in two models of kidney disease.靶向 OSBPL7 的化合物可增加 ABCA1 依赖性胆固醇流出,从而在两种肾病模型中维持肾功能。
Nat Commun. 2021 Aug 2;12(1):4662. doi: 10.1038/s41467-021-24890-3.
8
Mesenchymal Stromal Cell-Derived Extracellular Vesicles Pass through the Filtration Barrier and Protect Podocytes in a 3D Glomerular Model under Continuous Perfusion.间充质基质细胞衍生的细胞外囊泡穿过过滤屏障,并在连续灌注下的 3D 肾小球模型中保护足细胞。
Tissue Eng Regen Med. 2021 Aug;18(4):549-560. doi: 10.1007/s13770-021-00374-9. Epub 2021 Jul 27.
9
Vaccination Against Receptor for Advanced Glycation End Products Attenuates the Progression of Diabetic Kidney Disease.针对晚期糖基化终产物受体的疫苗接种可减轻糖尿病肾病的进展。
Diabetes. 2021 Sep;70(9):2147-2158. doi: 10.2337/db20-1257. Epub 2021 Jun 21.
10
Mitochondrial Dysfunction in Podocytes Caused by CRIF1 Deficiency Leads to Progressive Albuminuria and Glomerular Sclerosis in Mice.CRIF1缺乏导致足细胞线粒体功能障碍,进而引发小鼠进行性蛋白尿和肾小球硬化。
Int J Mol Sci. 2021 May 2;22(9):4827. doi: 10.3390/ijms22094827.